Back to results
CompletedPhase 3

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

NCT00855530

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis Administrative Office

Buenos Aires, Argentina

+10 additional locations

View on ClinicalTrials.gov
Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder — TrialFind